Guerin Mark Patrick 4
4 · Traws Pharma, Inc. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Guerin Mark Patrick
Chief Accounting Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-06-18−5,500→ 5,500 total→ Common Stock (5,500 underlying) - Exercise/Conversion
Common Stock
2024-06-10+5,500→ 41,476 total - Tax Payment
Common Stock
2024-06-18$0.47/sh−2,221$1,044→ 39,255 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary